ANAPTYSBIO, INC (ANAB) has 67 open-market insider trades by 20 insiders since 2017. The most active filer is Hamza Suria, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | Dir10% Owner | — | 5 | $118.9M | 2025-01-02 |
| Novo Holdings A/S | 10% Owner | — | 4 | $32.6M | 2017-08-21 |
| Hamza Suria | CEOPres | — | 12 | $22.1M | 2021-12-20 |
| Daniel Faga | CEOPres | — | 6 | $11.0M | 2026-03-27 |
| Oleg Nodelman | Dir10% Owner | — | 2 | $8.6M | 2021-05-04 |
| Patrick J. Heron | 10% Owner | — | 1 | $6.0M | 2017-01-31 |
| James N. Topper | Dir10% Owner | — | 1 | $6.0M | 2020-11-16 |
| Nader J. Naini | 10% Owner | — | 1 | $6.0M | 2018-05-11 |
| Marco Londei | — | — | 4 | $4.8M | 2019-11-27 |
| Nicholas Lydon | Dir | — | 2 | $3.1M | 2018-04-16 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| A/s Novo | Director | Sell | $249K | 2026-10-01 |
| John P. Schmid | Director | Sell | $1.2M | 2026-03-30 |
| Daniel Faga | CEO & President | Sell | $2.2M | 2026-03-27 |
| Eric J. Loumeau | CLO | Sell | $540K | 2026-02-11 |
| Magda Marquet | Director | Sell | $531K | 2026-01-15 |
| Eric J. Loumeau | CLO | Sell | $99K | 2026-01-08 |
Companies that share insiders with ANAB, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Paul F. Lizzul | Chief Medical Officer | Sell | $163K | 2026-01-08 |
| Daniel Faga | CEO & President | Sell | $639K | 2026-01-08 |
| Dennis Mulroy | CFO | Sell | $112K | 2026-01-08 |
| Dennis Mulroy | CFO | Sell | $86K | 2026-01-07 |
| Eric J. Loumeau | CLO | Sell | $439K | 2026-01-07 |
| Paul F. Lizzul | — | Sell | $101K | 2026-01-07 |
| Daniel Faga | CEO & President | Sell | $415K | 2026-01-07 |
| Dennis Mulroy | CFO | Sell | $145K | 2026-01-05 |
| Daniel Faga | CEO & President | Sell | $662K | 2026-01-05 |